MedPath
HSA Approval

CLAMIDE TABLET 5 mg

SIN07380P

CLAMIDE TABLET 5 mg

CLAMIDE TABLET 5 mg

April 3, 1993

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A10BB01

glibenclamide

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

HOVID Bhd.

Active Ingredients

GLIBENCLAMIDE

5.00MG

Glyburide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLAMIDE TABLET 5 mg - HSA Approval | MedPath